During the past decade, MD Anderson Cancer Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MD Anderson Cancer Center" #1 sponsor was "AB Science" with 2 trials, followed by "Celgene" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "NSABP Foundation Inc" with 2 trials sponsored and "Dartmouth-Hitchcock Medical Center" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MD Anderson Cancer Center" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Sanofi" with 1 trials as a collaborator and "US Oncology Research" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "MD Anderson Cancer Center" are "Colorectal Cancer" (2 trials), "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Carcinoma, Squamous Cell of Head and Neck" (1 trials) and "Chronic Lymphocytic Lymphoma" (1 trials). Many other conditions were trialed in "MD Anderson Cancer Center" in a lesser frequency.

Most popular intervention types in "MD Anderson Cancer Center" are "Drug" (13 trials), "Biological" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Carboplatin" (2 trials), "Masitinib" (2 trials), "Paclitaxel" (2 trials) and "cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "MD Anderson Cancer Center" are 11 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "MD Anderson Cancer Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in MD Anderson Cancer Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in MD Anderson Cancer Center, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".